Dual energy X-ray absorptiometry (DXA) was used to assess lumbar spine (L2-
4) and femoral neck bone mineral density (BMD) in 36 children taking either
carbamazepine or valproic acid for longer than one year, for generalized i
diopathic epilepsy. Patients were matched with controls. Biochemical parame
ters of bone mineral metabolism were also measured. BMD values at both the
femur neck and lumbar spine in both the carbamazepine and valproic acid gro
ups were not significantly different from that of the control group. Serum
levels of calcium were subnormal and alkaline phosphatase levels were high
in the carbamazepine group. Urinary calcium levels were significantly lower
in broth groups than in the control group (p less than or equal to 0.05) a
nd also significantly lower in the valproic acid group than in the carbamaz
epine group (p less than or equal to 0.05), There were no other significant
biochemical changes in either group. In conclusion, the results suggest th
at valproic acid and carbamazepine monotherapies have minimal effects on bo
ne mineral metabolism, but routine monitoring of risk and consideration of
prophylactic vitamin D supplementation is important.